Michael M. Wick

2011

In 2011, Michael M. Wick earned a total compensation of $788.3K as President, Chief Executive Officer and Chairman at MabVax Therapeutics Holdings, a 53% increase compared to previous year.

Compensation breakdown

Option Awards$274,300
Salary$514,000
Total$788,300

Wick received $514K in salary, accounting for 65% of the total pay in 2011.

Wick also received $274.3K in option awards.

Rankings

In 2011, Michael M. Wick's compensation ranked 6,518th out of 10,747 executives tracked by ExecPay. In other words, Wick earned more than 39.4% of executives.

ClassificationRankingPercentile
All
6,518
out of 10,747
39th
Division
Manufacturing
2,363
out of 3,960
40th
Major group
Chemicals And Allied Products
552
out of 1,038
47th
Industry group
Drugs
363
out of 786
54th
Industry
Pharmaceutical Preparations
287
out of 571
50th
Source: SEC filing on April 5, 2013.

Wick's colleagues

We found four more compensation records of executives who worked with Michael M. Wick at MabVax Therapeutics Holdings in 2011.

2011

Marc Steuer

MabVax Therapeutics Holdings

Former Senior Vice President, Business Development

2011

Wendy Wee

MabVax Therapeutics Holdings

Vice President, Finance and Controller

2011

Steven Schow

MabVax Therapeutics Holdings

Vice President, Research

2011

William Kaplan

MabVax Therapeutics Holdings

General Counsel

You may also like